Sign in to continue:

Thursday, February 5th, 2026

Author: minichart

Market UpdatesSingapore SGX stocks

Koh Brothers Group Ltd Resumes Uptrend: Singapore Retail Research Highlights Technical Buy Signals and Market Outlook

minichart
January 19, 2026

Broker Name: CGS International Date of Report: January 19, 2026 Excerpt from CGS International report. Report Summary Koh Brothers Group Ltd is highlighted for a technical buy, as the stock has broken out of...

Continue Reading 0
Market UpdatesSingapore SGX stocks

Figtree Holdings Ltd Confirms Bottoming Reversal: Singapore Retail Research Trendspotter Report (Jan 2026)

minichart
January 19, 2026

Broker Name: CGS International Date of Report: January 19, 2026 Excerpt from CGS International report. Figtree Holdings Ltd: The stock has confirmed a bottoming reversal, with technical signals pointing to a likely uptrend. Multiple...

Continue Reading 0
Market UpdatesSingapore SGX stocks

Singapore’s NODX Growth in 2026 Driven by AI and Semiconductor Demand Despite Global Headwinds

minichart
January 19, 2026

Broker: CGS International Date of Report: January 16, 2026 Excerpt from CGS International report. Singapore’s non-oil domestic exports (NODX) grew 6.1% year-on-year in December 2025, slowing from 11.5% in November, mainly due to softer...

Continue Reading 0
Market UpdatesSingapore SGX stocks

Tiong Woon Corp (TWC) Stock Analysis 2026: Undervalued Heavy Lift Solutions Provider Set for Growth in Asia and Middle East

minichart
January 19, 2026

Broker Name: CGS International Securities Date of Report: January 16, 2026 Excerpt from CGS International Securities report. Report Summary Tiong Woon Corporation (TWC), ranked #15 globally for crane operators, is trading at a significant...

Continue Reading 0
SGX corporate News

Keppel REIT Issues 923 Million New Units at S$0.96 Each Through Preferential Offering

minichart
January 18, 2026

Key Details of the Preferential Offering Offering Structure: The preferential offering was pro-rata and non-renounceable, with eligible unitholders entitled to 23 new units for every 100 existing units held as at 5:00 p.m. on...

Continue Reading 0
IPO

BitGo Holdings, Inc. IPO 2026: Company Overview, Competitive Advantages, and Growth Strategies Explained

minichart
January 17, 2026

BitGo Holdings, Inc. IPO Analysis: Investment Opportunity and Market Outlook Company Name: BitGo Holdings, Inc. Date of Prospectus: 2026 BitGo Holdings, Inc. (BTGO) IPO: Institutional Digital Asset Infrastructure Leader Makes NYSE Debut BitGo Holdings,...

Continue Reading 0
IPO

Leading Global Smart Device ODM: Market Share, Product Innovation, and Growth Strategy in 2024

minichart
January 17, 2026

Shanghai Longcheer Technology Co., Ltd. IPO: In-Depth Investor Analysis Shanghai Longcheer Technology Co., Ltd. Date of Prospectus: January 14, 2026 Shanghai Longcheer Technology IPO: Growth Ambitions, Cornerstone Backing, and Financial Insights for Investors IPO...

Continue Reading 0
IPO

Shanghai Longcheer Technology Co., Ltd. Global Offering 2026: IPO Details, Application Process, and Key Dates 2

minichart
January 17, 2026

Shanghai Longcheer Technology Co., Ltd. IPO Analysis – January 14, 2026 Company: Shanghai Longcheer Technology Co., Ltd. Date of Prospectus: January 14, 2026 Shanghai Longcheer Technology IPO: Comprehensive Investor Analysis, Offer Details, and Listing...

Continue Reading 0
IPO

Sichuan Biokin Pharmaceutical Hong Kong IPO: Innovative Oncology Pipeline, Growth Strategies & Global Expansion (2025 Prospectus Highlights)

minichart
January 17, 2026

Baili Pharmaceutical: Hong Kong IPO Analysis, Offer Details, Financials & Outlook Baili Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Baili Pharmaceutical’s Hong Kong IPO: Key Details, Institutional Interest, Financial Strength, and Investor...

Continue Reading 0
IPO

Sichuan Biokin Pharmaceutical Co., Ltd. Global Offering 2025: IPO Details, Application Process, and Key Dates Explained

minichart
January 17, 2026

Sichuan Biokin Pharmaceutical Co., Ltd. IPO Analysis: Key Investor Insights and Listing Outlook Sichuan Biokin Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Sichuan Biokin Pharmaceutical IPO: A Deep Dive into Offer Structure,...

Continue Reading 0